SEC Filing Analysis: CORCEPT THERAPEUTICS INC (CORT)

Executive Summary

• Trading Significance: Low
• Key Takeaway: The CEO of Corcept Therapeutics sold approximately $3.0 million worth of company stock across several transactions as part of a pre-scheduled Rule 10b5-1 trading plan.
• Market Impact: The transaction is considered immaterial, representing a negligible percentage of the company's market capitalization and the insider's total holdings. It is unlikely to have a meaningful impact on the stock.

Company Information

Field	Value
Company	CORCEPT THERAPEUTICS INC
Ticker Symbol	CORT
CIK	0001088856
Industry	PHARMACEUTICAL PREPARATIONS [2834]

Insider Information

Field	Value
Name	BELANOFF JOSEPH K
CIK	0001286199
Title/Position	Chief Executive Officer
Relationship	Director, Officer

Transaction Details

Field	Value
Form Type	4
Transaction Date	2025-11-03 to 2025-11-05
Transaction Code	S (Sale)
Security Type	Common Stock
Shares Involved	40,000
Price Per Share	~$74.58 (Weighted Average)
Total Value	$2,983,050.52
Shares Owned After	2,741,370
Ownership Type	Indirect

Financial Impact Assessment

Transaction Materiality

Metric	Value
Transaction Value	$2,983,051
% of Market Cap	0.039%
Shares Transacted	40,000
% of Shares Outstanding	0.038%
Post-Transaction Ownership	2,741,370 shares (2.60% of outstanding)
Materiality Assessment	Low

Impact Evaluation

• Market Cap Context: The $3.0M sale is minor for a company with a market capitalization of $7.74 billion. Such transactions are routine for executives at this level.
• Ownership Concentration: The sale represents a very small portion (~1.4%) of the CEO's holdings. His remaining stake of 2.60% demonstrates continued significant alignment with shareholder interests.
• Transaction Significance: The sale is classified as low significance. Both the value relative to market cap and the shares relative to outstanding float are well below the 0.1% threshold for moderate significance. The pre-arranged nature of the sale via a 10b5-1 plan further diminishes its importance as a real-time indicator of insider sentiment.

Market Impact Analysis

Stock Impact Prediction

• Direction: Neutral
• Reasoning: The transaction is too small to be material and was executed under a pre-disclosed trading plan, which markets typically disregard as a new signal.

Volume & Sentiment

• Expected Volume Impact: Negligible. The transaction size is a fraction of typical daily trading volume for CORT.
• Sentiment Indicator: Neutral. This is a planned liquidity event for the executive, not a strategic move based on new information.

Additional Context

Transaction Notes

• Special Circumstances: The filing explicitly states all sales were made pursuant to a Rule 10b5-1 trading plan adopted on November 26, 2024. This indicates the sales were pre-scheduled and not based on current events.